Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

The number of young Filipinos infected with human immunodeficiency virus has increased by 500% prompting the Department of Health to request for the declaration of a national public health emergency ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more t… ...

HIV and AIDS (acquired immunodeficiency syndrome) surveillance has shown that Filipinos who are newly diagnosed with HIV are getting younger. The DOH noted that the predominant age group has shifted ...

Health Doctors near HIV cure with ‘previously impossible’ discovery: ‘We have never seen anything close to as good’ By Diana Bruk Published June 5, 2025, 3:01 p.m. ET ...

MANILA, Philippines — The Department of Health (DOH) has urged President Marcos to declare human immunodeficiency virus (HIV) a national public health emergency due to a surge in new cases in the ...

In 2012, the FDA approved Truvada, also made by Gilead Sciences, making it the first PrEP medication for HIV prevention in uninfected adults in the United States – but “even though PrEP has ...